
Arshad M. Khanani MD, MA, FASRS
Advertisement
Articles by Arshad M. Khanani MD, MA, FASRS


Dr Khanani shared his first-time results talk during an AAO specialty day

Arshad M. Khanani, MD, MA, FASRS, highlights the fluid resolution with faricimab and the need for loading doses, especially in high-needs switch patients with nAMD or DME.

Arshad M. Khanani, MD, MA, FASRS, discusses rapid improvement with faricimab in several anatomic parameters in treatment-naïve and previously treated patients with nAMD and DME in the TRUCKEE and TAHOE studies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
EuDEC 2026: ectoine eye drops show meaningful symptom and tear film improvements in dry eye disease
2
Lumvoa gains US FDA approval for thyroid eye disease with class-first broad label
3
Phaco-GSL outperforms in acute angle-closure glaucoma over chronic cases, 2-year study finds
4

